Keros Therapeutics, Inc. · NASDAQ:KROS
Lerner Lorena Raquel sold 3,568 Keros Therapeutics, Inc. shares (Form 4)
Traded Aug 18, 2026 · Filed Aug 20, 2026
On Aug 18, 2026, Lerner Lorena Raquel (Chief Scientific Officer) sold 3,568 Keros Therapeutics, Inc. shares at US$10.29 for US$36,715, leaving 27,559 shares. Filed Aug 20, 2026 (Form 4).
- Sold
- 3,568 shares
- Price
- US$10.29
- Value
- US$36,715
- Holding after
- 27,559 shares
- Trading plan
- No
- Role
- Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Common Stock | Sale | 3,568 | US$10.29 | 27,559 | Direct |